S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

TruBridge Investors Targeted in Securities Fraud Investigation

A 10.5% single-day stock price drop following a delayed annual report has triggered a formal investigation into TruBridge, Inc. The Rosen Law Firm is currently vetting potential securities claims, alleging the healthcare revenue cycle management company misled investors regarding its financial health and historical accounting practices.

TruBridge Investors Targeted in Securities Fraud Investigation
Photo: Bio & News

The scrutiny centers on a March 17, 2026, disclosure where TruBridge admitted it could not file its annual report for the year ending December 31, 2025. Management cited the discovery of accounting errors spanning back to 2023, specifically involving revenue recognition, stock-based compensation, and capitalized software costs. These discrepancies necessitate revisions to financial statements previously filed for 2023 and 2024, as well as adjustments to multiple quarters in 2025.

Following the announcement, TruBridge shares plummeted $1.84 to close at $15.75. Shareholders who suffered losses during this period are now being sought by the Rosen Law Firm to participate in a potential class action. The firm, which operates on a contingency basis, is collecting information from affected investors via their legal portal and toll-free line to determine the scope of the recovery effort.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!